EP3311824
CD47 TARGETED THERAPIES FOR THE TREATMENT OF INFECTIOUS DISEASE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
5.2.2014EP published:
25.3.2020EP application number:
17194591.8
EPO information:
European Patent Register
Max expiry date:
4.2.2034
Title:
CD47 TARGETED THERAPIES FOR THE TREATMENT OF INFECTIOUS DISEASE
Timeline
Today
5.2.2014EP application
25.3.2020EP Publication
Owner
Name:
The Board of Trustees of the Leland Stanford Junior UniversityAddress:
Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038, US
Name:
The United States of America, as represented by The Secretary, Department of Health and Human ServicesAddress:
6011 Executive Boulevard Suite 325, MSC 7660, Bethesda, Maryland 20892-7660, US
Name:
The Regents of the University of CaliforniaAddress:
1111 Franklin Street, 12th Floor, Oakland, CA 94607-5200, US
Inventor
Name:
WEISKOPF, KippAddress:
Brookline Massachusetts 02445, US
Name:
HASENKRUG, Kim J.Address:
Victor, MT Montana 59875, US
Name:
STODDART, Cheryl A.Address:
Pacifica, CA California 94044, US
Name:
MCCUNE, Joseph M.Address:
San Francisco, CA California 94117, US
Name:
WEISSMAN, Irving L.Address:
Stanford, CA California 94305, US
Priority
Number:
201361761133 PDate:
5.2.2013Country:
US
Classification
Categories:
A61K 35/00, A61P 31/12